New England School of Homeopathy

Donate to the Foundation for Homeopathic Education


Donations can be made to FHE  directly via PayPal:


Or you can make a donation by check/credit card (V/M/D/AX) and mail it to:
356 Middle Street
Amherst, MA 01002
(413) 256-5949

Any questions, please contact us.

Monies raised from grants and donations are used to fund, among other things, the following:

CAM Research
The Foundation for Homeopathic Education, in association with Herscu Laboratories 501c, is helping to develop systems that promote reliable testing and research into CAM approaches such that care providers can have reliable and unbiased information about the efficacy and mechanism of action of particular CAM offerings.

Public Health Infrastructure and CAM
As an extension of the influenza treatment trials, FHE is researching and developing public health tools to be utilized in the CAM arena. The goal is two-fold; to develop tools that can help to predict, characterize, and identify effective treatment for a rapidly shifting epidemic, and also to create the necessary infrastructure to distribute such tools quickly and efficiently.

A pilot study is currently on-going in partnership with the Helfgott Center in Portland, Oregon. The study is a controlled trial on treatment of naturally-occurring influenza with homeopathic medicine. Beyond carrying out a well-designed controlled trial to examine the efficacy of homeopathic treatment on influenza, the broader aim of the study is to develop a systematic way to determine the appropriate treatment for the current epidemic as well as generate a predictive tool for identifying those who will benefit from the treatment that is applicable in a public health setting.

FHE has also developed review papers on influenza trial design methodology and CAM study approaches, as well as overviews on homeopathic design quality considerations and history of homeopathy in influenza treatment.

Influenza Tracking and Tools
FHE has launched a specific website to present and provide updates on our research with CAM, public health, and influenza. Please see more information at

Database Development and Population

Including a fully functional database to track current influenza symptoms in order to develop real-time monitoring of genus epidemicus and shifts across time.

Public Health Infrastructure Projects

Such as a CAM version of the CDC; something with the ability to automate the distribution of real-time information on flu relevant to CAM providers, as well as to conventional medicine providers utilizing CAM treatments.

Military Applications for CAM (MACAM)
FHE is involved in a long term project aimed at developing medical applications for CAM therapies in military settings, with a focus on acute physical and psychological trauma as well as the long term effects of trauma such as under the broad heading of PTSD. Application development is focused upon creating on-site, easily applied clinical prediction tools that aid in the rapid and accurate assessment and differentiation of acute and chronic conditions, and lead to effective and individualized treatment decisions.

CAM Treatment Targeting
Similar to the pharmaceutical research direction, Herscu Laboratory is developing tools to aid in the development and targeting of CAM therapies. Applications are based on the identification of clinically relevant sub-groups within heterogeneous trial populations, such that therapy can be targeted more effectively towards the individuals who will benefit the most, in a predictable and reproducible way. FHE is also researching methodologies for efficiently identifying novel uses for existing natural medicines.

CAM Trial Development
FHE, in conjunction with partners like The Helfgott Research Center, is developing high-quality clinical trials in various CAM modalities. The main research goal is to reproduce the standardized elements of conventional drug trials that are applicable to CAM studies of similar focus, and to innovate and update trial design that is out-dated or inappropriate. By helping to design acceptable and reproducible trials, FHE hopes to help generate productive discussion on the role of CAM therapies in modern medicine.